RADA16 for Adult Tonsillectomy
NCT: NCT07060495 · RECRUITING
Brief Summary
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage. Participants will: * Undergo tonsillectomy procedure. * Receive and fill out a survey sent via email every 2 days following their procedure for 15 days and track their symptoms.
Frequently Asked Questions
What is RADA16 for Adult Tonsillectomy?
RADA16 for Adult Tonsillectomy is a clinical trial registered under NCT07060495. Current status: RECRUITING.
What is the status of NCT07060495?
The current status of NCT07060495 (RADA16 for Adult Tonsillectomy) is: RECRUITING.
When did RADA16 for Adult Tonsillectomy start?
RADA16 for Adult Tonsillectomy started on 2025-09-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.